Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACE: ALDH Bright Cells for Intermittent Claudication
NCT01774097Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jun 2013
- Primary completion
- Aug 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ALD-301 in peripheral artery disease (PAD), intermittent claudication (IC), sponsored by UTHealth Houston. Started Jun 2013; status: completed.
02
Drugs
ALD-301
03
Conditions
peripheral artery disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT01774097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774097.